C3is, a prominent company in the industry, experienced a significant downturn as its shares dropped by a staggering 67%, reaching a new 52-week ...

EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT) revealed on Monday afternoon that it has commenced an underwritten public offering of $175 million in common stock. ...